Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Active-controlled, Cross-over Study to Assess Efficacy and Safety of 3 Free Doses of Glycopyrrolate With Beclomethasone/Formoterol pMDI for the Treatment of COPD Patients
Brief Summary: dose-finding study to assess the optimal dose of glycopyrrolate daily dose on top of BDP/FF in COPD patients.


Options:
A: Arm Label: Glyco 25; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrrolate | Arm Label: Glyco 50; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrrolate | Arm Label: Glyco 100; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrrolate | Arm Label: BDP/FF 400/24; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Glyco 25 | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Glyco 50 | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Glyco 100 | Intervention Type: DRUG; Name: Comparator; Assigned to Arm(s): BDP/FF 400/24
B: Arm Label: fluticasone furoate/umeclidinium bromide/vilanterol; Type: EXPERIMENTAL; Interventions: Drug: fluticasone furoate (FF), Drug: vilanterol (VI), Drug: umeclidinium bromide (UMEC) | Arm Label: fluticasone furoate/vilanterol; Type: EXPERIMENTAL; Interventions: Drug: fluticasone furoate (FF), Drug: vilanterol (VI) | Arm Label: umeclidinium bromide/vilanterol; Type: EXPERIMENTAL; Interventions: Drug: vilanterol (VI), Drug: umeclidinium bromide (UMEC) | Intervention Type: DRUG; Name: fluticasone furoate (FF); Assigned to Arm(s): fluticasone furoate/umeclidinium bromide/vilanterol, fluticasone furoate/vilanterol | Intervention Type: DRUG; Name: vilanterol (VI); Assigned to Arm(s): fluticasone furoate/umeclidinium bromide/vilanterol, fluticasone furoate/vilanterol, umeclidinium bromide/vilanterol | Intervention Type: DRUG; Name: umeclidinium bromide (UMEC); Assigned to Arm(s): fluticasone furoate/umeclidinium bromide/vilanterol, umeclidinium bromide/vilanterol
C: Arm Label: PT003 (Dose 1); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 2); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 3); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 4); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 5); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT001; Type: EXPERIMENTAL; Interventions: Drug: PT001 | Arm Label: PT005; Type: EXPERIMENTAL; Interventions: Drug: PT005 | Arm Label: Spiriva® Handihaler®; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium inhalation powder | Intervention Type: DRUG; Name: PT003; Assigned to Arm(s): PT003 (Dose 1), PT003 (Dose 2), PT003 (Dose 3), PT003 (Dose 4), PT003 (Dose 5) | Intervention Type: DRUG; Name: PT001; Assigned to Arm(s): PT001 | Intervention Type: DRUG; Name: PT005; Assigned to Arm(s): PT005 | Intervention Type: DRUG; Name: Tiotropium inhalation powder; Assigned to Arm(s): Spiriva® Handihaler®
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aclidinium bromide | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol Fumarate | Arm Label: 5; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC); Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Aclidinium bromide; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Formoterol Fumarate; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 5

Answer: A